Literature DB >> 3638148

Urinary kallikrein excretion during inhibition of endogenous angiotensin II in the pig.

B R Binder, M Maier, H Rana, M Starlinger, Z Zhegu.   

Abstract

This study was performed to assess the possible contribution of endogenous angiotensin II (AII) to the regulation of urinary kallikrein excretion. The AII antagonist saralasin or the saline vehicle was infused into the aorta above the renal arteries of pigs under halothane-O2/N2O anaesthesia. Systemic and renal functional parameters were followed for 140 min and during stimulation of the reninangiotensin system by haemorrhage. Urinary kallikrein excretion, determined as kininogenase activity, was increased immediately upon both initiation and termination of the 2 h saralasin infusion into pigs not subjected to haemorrhage. Renal cortical blood flow (RCBF) was maintained, in both saline and saralasin-treated animals at blood pressures as low as 70 mm Hg, while glomerular filtration rate was dissociated during saralasin infusion. As long as RCBF was maintained, urinary kallikrein excretion rate was elevated during the progressive hypotension in both saline and saralasin-treated animals. These findings confirm a close relationship between the maintenance of RCBF and increased activity of the kallikrein-kinin system whether or not AII is antagonized, and indicate that during haemorrhage the kallikrein-kinin system is stimulated by a mechanism not involving AII.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3638148      PMCID: PMC1916975          DOI: 10.1111/j.1476-5381.1986.tb10237.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Angiotensin receptors.

Authors:  M A Devynck; P Meyer
Journal:  Biochem Pharmacol       Date:  1978-01-01       Impact factor: 5.858

Review 2.  Stimulation of the renal kallikrein-linin system by vasoactive substances and its relationship to the excretion of salt and water.

Authors:  I H Mills; L F Obika; P A Newport
Journal:  Contrib Nephrol       Date:  1978       Impact factor: 1.580

3.  Release of a prostaglandin E-like substance from canine kidney by bradykinin.

Authors:  J C McGiff; N A Terragno; K U Malik; A J Lonigro
Journal:  Circ Res       Date:  1972-07       Impact factor: 17.367

4.  Kallikrein, kinins and blood pressure - effects of angiotensin-converting enzyme inhibition.

Authors:  C I Johnston; B Clappison; B P McGrath; P G Matthews; J A Millar; W P Anderson
Journal:  Prog Biochem Pharmacol       Date:  1980

5.  Linking the kallikrein and renin systems via activation of inactive renin: new data and a hypothesis.

Authors:  J E Sealey; S A Atlas; J H Laragh
Journal:  Am J Med       Date:  1978-12       Impact factor: 4.965

6.  Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens.

Authors:  M Maier; K F Austen; J Spragg
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

7.  The effect of cations on the activity of human urinary kallikrein.

Authors:  W Lieberthal; N B Oza; D B Bernard; N G Levinsky
Journal:  J Biol Chem       Date:  1982-09-25       Impact factor: 5.157

8.  Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme).

Authors:  H Y Yang; E G Erdös; Y Levin
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

9.  The effect of hemorrhagic hypotension on urinary kallikrein excretion, renin activity, and renal cortical blood flow in the pig.

Authors:  M Maier; M Starlinger; M Wagner; D Meyer; B R Binder
Journal:  Circ Res       Date:  1981-03       Impact factor: 17.367

10.  Regulation of kallikrein and renin release by the isolated perfused rat kidney.

Authors:  J Misumi; F Alhenc-Gelas; M Marre; J Marchetti; P Corvol; J Menard
Journal:  Kidney Int       Date:  1983-07       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.